Page last updated: 2024-08-22

phenethyl isothiocyanate and Leukemia, Myeloid

phenethyl isothiocyanate has been researched along with Leukemia, Myeloid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhalla, K; Chen, G; Fiskus, W; Garcia-Manero, G; Hu, Y; Huang, P; Jia, Y; Keating, M; Lu, W; Wei, Y; Yang, H; Zhang, H; Zhang, W	1

Other Studies

1 other study(ies) available for phenethyl isothiocyanate and Leukemia, Myeloid

Article	Year
Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate. Blood, 2010, Oct-14, Volume: 116, Issue:15 Topics: Antioxidants; Base Sequence; Cell Line, Tumor; Cell Survival; DNA Primers; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; Isothiocyanates; Leukemia; Leukemia, Myeloid; NADPH Oxidases; NF-E2-Related Factor 2; Oxidation-Reduction; Reactive Oxygen Species; Tumor Cells, Cultured; U937 Cells; Vorinostat	2010

Article

Year

Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate.

Blood, 2010, Oct-14, Volume: 116, Issue:15

Topics: Antioxidants; Base Sequence; Cell Line, Tumor; Cell Survival; DNA Primers; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; Isothiocyanates; Leukemia; Leukemia, Myeloid; NADPH Oxidases; NF-E2-Related Factor 2; Oxidation-Reduction; Reactive Oxygen Species; Tumor Cells, Cultured; U937 Cells; Vorinostat

2010